HUBERT HSING CHUANG to Vincristine
This is a "connection" page, showing publications HUBERT HSING CHUANG has written about Vincristine.
Connection Strength
0.109
-
Chimeric antigen receptor T-cell therapy's role in antiphospholipid syndrome: a case report. Br J Haematol. 2020 02; 188(3):e5-e8.
Score: 0.033
-
Positron emission tomography-computed tomography predictors of progression after DA-R-EPOCH for PMBCL. Blood Adv. 2018 06 12; 2(11):1334-1343.
Score: 0.030
-
Single-institution experience in the treatment of primary mediastinal B cell lymphoma treated with immunochemotherapy in the setting of response assessment by 18fluorodeoxyglucose positron emission tomography. Int J Radiat Oncol Biol Phys. 2015 May 01; 92(1):113-21.
Score: 0.024
-
Prospective phase II study of rituximab with alternating cycles of hyper-CVAD and high-dose methotrexate with cytarabine for young patients with high-risk diffuse large B-cell lymphoma. Br J Haematol. 2013 Dec; 163(5):611-20.
Score: 0.022